Noblesville is set to pick up a major life sciences tenant, as BioLife Solutions plans to shift its Indianapolis-based operations into a nearly 40,000-square-foot facility at Washington Business Park, according to city officials. The relocation plan, unanimously approved by the Noblesville Common Council, is expected to retain about 20 existing jobs in the area and add roughly 10 new full-time positions as the company scales up production. Construction is scheduled to start in spring 2026, with initial move-in targeted for spring 2027 and manufacturing operations slated to follow in summer 2027.
Project details and operations
The build-to-suit facility is designed to support biomanufacturing, hardware support, product cold storage and fulfillment operations as BioLife centralizes more of its supply chain for cell-and-gene therapies. Company leaders and city officials have outlined a phased approach, with site work and equipment installation sequenced ahead of the manufacturing ramp-up. WTHR
Council sign-off and local reaction
The Noblesville Common Council signed off on the economic development agreement in an 8-0 vote, clearing the way for the relocation package that will support the project, officials say. Andrew Murray, who manages Washington Business Park, called BioLife "a great addition" and noted the park is advancing ahead of schedule. Mayor Chris Jensen said the move fits squarely with the city's vision for job growth and advanced manufacturing, while BioLife CEO Roderick de Greef thanked the city for its backing and pointed to Noblesville's infrastructure as a key factor in making the expansion possible. WTHR
Washington Business Park at a glance
Washington Business Park is a roughly 140-acre industrial campus located north of 146th Street and east of State Road 37, marketed as build-to-suit space for manufacturing and logistics users. The development is fully served by city utilities and can accommodate buildings ranging from tens of thousands of square feet to more than 200,000 square feet, giving life-science and related firms room to grow within the same campus. ChooseNoblesville
About BioLife and the broader market
BioLife Solutions develops and supplies cell-processing tools, biopreservation media and services for the cell and gene therapy market, and the company has reported recent revenue growth as demand for CGT products continues to expand. The planned Noblesville facility is intended to strengthen its manufacturing and cold-chain capacity as more therapies advance through clinical trials and move closer to commercialization. PR Newswire
What to watch next
Analysts and developers have flagged Noblesville as one of the region's fast-growing industrial and innovation hubs, a trend highlighted in a recent Cushman & Wakefield report that labeled the city an "engine of innovation" within the Indianapolis area. As site prep and permitting move ahead for the BioLife project, officials say the precise construction schedule and equipment-installation timeline will come into sharper focus. Cushman & Wakefield
